I want to do in vivo injections of RITC (rhodamine-b-isothiocyanate) into the eye and PHAL injections into another brain structure, followed by immunohistochemistry with anti-PHAL antibody and a fluorescent secondary antibody.
Will the RITC labeling persist through the immunohistochemistry procedures? I am worried that the 0.3% Triton used together with the antibodies may extract the RITC from the tissue. Would the immuno also work without Triton, perhaps? Or are my doubts just unnecessary?
Another possibility would of course be injecting CTB into the eye instead of RITC, and doing different immunofluorescence via anti-CTB and anti-PHAL. But RITC is cheaper and requires less antibody usage, so I want to know if it works.